ROUNDUP / New York Stocks Conclusion: Dow grabs its teeth at 30,000 points | 12/3/20

NEW YORK (dpa-AFX) – The Dow Jones Industrial (Dow Jones 30 Industrial) did not hold out a new attack on the 30,000 points on Thursday. The brand remained competitive, after a sprint to 30,110 points and thus close to the previous record high, investors were intimidated again late. In the end, Wall Street’s barometer defended a plus of 0.29 percent to 29,969.52 points. The attempt to permanently leave the 30,000 points behind had failed several times before.

Other indices set further highs in the course of the day before they too lost momentum in late trading. The market-wide S&P 500 ultimately even plunged just under 0.06 percent and ended at 3666.72 points. The technology-heavy NASDAQ 100, on the other hand, was just above water at 12,467.13 meters, which is an increase of 0.09 percent.

After a lame day before, investors on Thursday occasionally ventured a little more courageously onto the floor. They not only hoped for the vaccinations to start soon, but also for progress in Washington in the months-long struggle for further corona aid. Later, however, a report clouded the picture that vaccine pioneers Pfizer and BioNTech were experiencing problems in their supply chains.

A media report about obstacles in the supply of raw materials had a negative effect. As the “Wall Street Journal” wrote, Pfizer originally flirted with 100 million vaccine doses this year, but is currently only assuming half the amount. However, the number of 50 million cans had been around for a long time, and so the reaction at Biontech was ultimately rather small with a discount of two percent compared to the recent rally of the papers. Pfizer closed 1.7 percent lower.

A major pillar of the Dow was Boeing, which rose six percent to its highest level since March. Shares from the aviation industry were generally in high demand again on Thursday, American Airlines even rose by 8.3 percent. At Boeing, there was also the fact that the low-cost airline Ryanair gave the crisis jet 737 Max a vote of confidence with a larger order.

But the papers of the pharmacy and drugstore chain Walgreens Boots Alliance, which rose by 7.5 percent, became the front-runner in the Dow. The day before it was said that the company was preparing to administer corona vaccines across the US. The rally this triggered continued. They showed new momentum above the chart-relevant 200-day average line.

On the Nasdaq stock exchange, the Tesla shares attracted attention once again, which these days are facing a difficult hurdle with the 600 dollar mark. On Thursday it was up 4.3 percent, but this was not quite enough for a new test of this brand. It was supported by the fact that Goldman Sachs recommended buying the shares with a price target of $ 780.

The shares of the stock exchange novice Snowflake recorded a price jump of 16 percent, in the meantime it was even enough for a record of 343 dollars. Analysts praised the software developer’s increase in sales. A sales outlook initially met with disappointed voices was described by experts as conservative.

The feedback on the numbers of the retailer Kroger was less good, here the papers fell by 4.4 percent on Thursday. The supermarket chain said the outlook indicated that the sales growth achieved in times of the pandemic may not be permanent

The euro continued its recent soaring as high as $ 1.2175 on Thursday. Finally, $ 1.2148 was paid for the common currency. The European Central Bank (ECB) set the reference rate at 1.2151 (Wednesday: 1.2066) dollars. The dollar cost 0.8230 (0.8287) euros.

The prices of US government bonds ended their most recent slide on Thursday for the time being. The futures contract for ten-year Treasuries (T-Note-Future) rose by 0.15 percent to 137.71 points. The yield on the ten-year bond was 0.91 percent./tih/he

— By Timo Hausdorf, dpa-AFX —

–